USANA Health Sciences
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
16.03 | 41.41 | -61.29% | 15.9 | +0.8099% |
| P/S |
|
1.11 | 4.2 | -73.58% |
|
|
| P/BV |
|
2.06 | 16.39 | -87.45% |
|
|
| P/FCF |
|
21.73 | 20.8 | 4.47% |
|
|
| Ev/Ebitda |
|
6.22 | 26.36 | -76.42% |
|
|
| Ev/S |
|
0.7659 | 4.66 | -83.55% |
|
|
| Ev/FCF |
|
12.56 | 75.76 | -83.42% |
|
|
| E/P |
|
0.0523 | 0.093 | -43.77% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
4/10
|
12.32 | 19.43 | -36.6% | 13.7 | -10.07% |
| ROE |
|
12.83 | 52.55 | -75.59% |
|
|
| ROA |
|
10.08 | 8.12 | 24.21% |
|
|
| ROIC |
|
26.26 | 16.22 | 61.93% |
|
|
| ROS |
|
6.93 | 11 | -36.97% |
|
|
| ROCE |
|
18.72 | 78.91 | -76.28% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.1164 | 2.98 | -96.09% | 0.087 | +33.76% |
| Nеt Debt/Ebitda |
|
-2.8 | 2.51 | -211.3% |
|
|
| Debt/Ratio |
|
0.0209 | 0.3903 | -94.65% |
|
|
| Debt/Equity |
|
0.0344 | 2.11 | -98.37% |
|
|
| Debt/Net Income |
|
0.207 | 6.44 | -96.78% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 2.92 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 10.43 | -100% | ||
| DSI |
|
0 | 0.9365 | -100% |
|
|
| Average dividend growth |
|
0 | 1.93 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 2.68 | -100% |
|
|
| Average percentage for payments |
|
55.72 | 83.73 | -33.45% |
|
|
| Difference from average difference in sector |
|
-2.92 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-13.11 | 51.31 | -125.55% | ||
| Growth impulse Ebitda in 5 years |
|
-15.79 | 11.58 | -236.36% | ||
| Growth impulse Net Income in 5 years |
|
-36.53 | -4.21 | 767.7% | ||
| Growth impulse FCF in 5 years |
|
-49.05 | 5.38 | -1011.71% | ||
| Growth impulse EPS in 5 years |
|
-25.23 | -8.16 | 209.19% |
IP Score
4.85/10
